Video Journal of Hematology & Hematological Oncology (VJHemOnc)

An action packed day 3 here at #ASH24! 🎥 🗞️🩸🇺🇸 Today we’ve spoken to: 🌟 Sanam Loghavi about all things #AMLsm 🌟 Omar Nadeem MD about exploring innovative therapies for high-risk smoldering myeloma and relapsed/refractory multiple myeloma 🌟 Julio Chavez MD on advances in #lymphoma care 🌟 Issa Khouri who spoke on adding inotuzumab ozogamicin to a melphalan + fludarabine redced-intensity conditioning regimen shows promise for allogeneic transplant in ALL and aggressive lymphoid malignancies 🌟 Shai Shimony on new insights in #AML and #BPDCN care 🌟 Jack Khouri, MD, FACP about an EASIX-based predictive model for ICANS & CRS after CAR-T therapy & Outcomes of teclistamab in pts with RRMM with prior exposure to BCMA-directed therapy 🌟 Enrique M. Ocio who discussed long-term efficacy and safety of isatuximab, bortezomib, lenalidomide, and dexamethasone (Isa-VRd) in newly diagnosed patients with #MultipleMyeloma patients not eligible for transplant or with no immediate transplant intent 🌟 Marina Konopleva who discussed innovative therapies presented at #ASH24 such as: tagraxofusp which shows promise in BPDCN with rapid hematopoiesis recovery & novel non-transplant options emerging for high-risk TP53 myeloid disease & many more! Stay tuned as we continue to share our exclusive coverage 👀 👉 https://lnkd.in/eBQtCaCs #Hematologynews #HemOnc

Want to hear about how the 5th iteration of the WHO’s classification system for #AML has changed the number of #genetically defined categories?🧬🩸 🎥 Then watch our interview from #ASH24 w/ the wonderful Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center 👉 https://ow.ly/qxSE50UsnuS #AMLsm #Leusm

New #Podcast Alert! 🎙️🚨 Advancing treatment for #BPDCN: current therapies, a deep dive into #tagraxofusp, & emerging novel agents🩸 🎧 Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center discusses: 💡 The challenges in treating this disease and reviews current therapeutic options such as #chemotherapy, #tagraxofusp, and #transplantation 💡The #CD123-targeted agent #tagraxofusp, addressing patient eligibility, the role of #tagraxofusp in bridging to #transplantation, and real-world data on its use 💡Insights into ongoing #clinicaltrials and emerging treatments for #BPDCN, including novel #CD123-#targetedtherapies, combination strategies, #BCL2inhibitors, and #immunotherapeutic approaches Tune in 👉 https://lnkd.in/eV3h_NSw Use the time codes to skip to your favourite part of each episode 👀 SUBSCRIBE so you don't miss any future episodes📱 #VJHemOnc #Hematologynews #MMsm

Join us for our Post-ASH 2024 #AML Highlights!🔬🩸✨ 🗓️ 31 January 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Naval Daver 🌟 Moderators - Charlie Craddock CBE, Jessica Altman & Univ.-Prof. Dr. med. Marion Subklewe REGISTER NOW 👉 https://lnkd.in/eFBbs63Q Take a look at the agenda 👉 https://lnkd.in/e6hFnubQ #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

Join us for our Post-ASH 2024 #CML Highlights!🔬🩸✨ 🗓️ 24 January 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Jorge Eduardo Cortes, MD 🌟 Moderators - Elisabetta Abruzzese & Mhairi Copland REGISTER NOW 👉 https://lnkd.in/eTGFqe-X Take a look at the agenda 👉 https://lnkd.in/ejrEBU9R #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

Spotlight on: Spotlight on: Prolonging #Remission In Patients With #AML 🗞️🩸 In this exclusive case study, hear from David Sallman, MD, Moffitt Cancer Center, who introduces a case featuring a 64-year-old male with #acutemyeloidleukemia (#AML) Dr Sallman discusses first-line treatment approaches, consolidation, and options for maintenance therapy, with the overall goal of prolonging remission in this patient 🔦 Take a look 👉 https://lnkd.in/eiwy4dSy #VJHemOnc #Leusm #Hematologynews

Join us for our Post-ASH 2024 #Lymphoma Highlights!🔬🩸✨ 🗓️ 30 January 2025 📍Webinar 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Chair - Wendy Osborne 🌟 Moderators - Tycel Phillips and Laurie Sehn REGISTER NOW 👉 https://lnkd.in/ezUvgjSZ Take a look at the agenda 👉 https://lnkd.in/exSrNzgb #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

What a blast #ASH24 has been! 🎥🗞️🩸🇺🇸 Thank you to everyone who stopped by the VJHemOnc booth 🧡 And a BIG thank you to everyone who spoke with us 🎙️💡 Stay tuned as we continue to share our exclusive coverage 👀 👉 https://lnkd.in/eBQtCaCs See you next year! ✈️ #Hematologynews #HemOnc Sanam Loghavi David Sallman Claudio Cerchione Meral Beksac Rahul Banerjee Adrián Mosquera Orgueira

Join us for our Post-ASH 2024 Highlights!🔬🩸✨ 🗓️ 23-7 February 2025 📍Webinar Series 💻 Featuring presentations & discussions on selected abstracts from the 66th ASH Annual Meeting and Exposition Don’t miss the chance to expand your knowledge, unpack groundbreaking findings from ASH & join the conversation 🔦 With leading #HemOnc experts: 🌟 Prof. Barbara Eichhorst 🌟 Dr Rakesh Popat 🌟 Dr Amer Zeidan 🌟 Dr Wendy Osborne 🌟 Dr Naval Daver 🌟 Prof. Claire Harrison 🌟 Jorge Cortes REGISTER NOW 👉 https://lnkd.in/ekpmxeaz #WebinarSeries #ASH24 #Hematologynews #MedicalEducation #VJHemOnc #Hematologyupdates #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma

In less than 1 hour Saad Z. Usmani is going to take over our Twitter account to bring you live updates from one of the key #ASH24 sessions on #MultipleMyeloma 🗞️🩸📱 Stay tuned for expert insights and the latest breakthroughs - give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀 #HemOnc #MMSM